Skip to main content

News Archive

News Archive - Scott LaFee

Longitudinal Study of Brain Aging and Cognitive Change Receives $19 Million Grant

June 15, 2020

Researchers at UC San Diego School of Medicine, with colleagues elsewhere, will receive almost $19 million over five years for the fourth phase of the Vietnam Era Twin Study of Aging, which investigates cognition, aging and the risk for mild cognitive impairment and Alzheimer’s disease.

Putting ‘Super’ in Natural Killer Cells

June 11, 2020

Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.

Cheryl Anderson Named Founding Dean of School of Public Health at UC San Diego

June 1, 2020

Dr. Cheryl Anderson, professor and interim chair of the Department of Family Medicine and Public Health in the School of Medicine at the University of California San Diego, has been named founding dean of The Herbert Wertheim School of Public Health and Human Longevity Science.

Cheryl Anderson Named Founding Dean of School of Public Health at UC San Diego

June 1, 2020

Dr. Cheryl Anderson, professor and interim chair of the Department of Family Medicine and Public Health in the School of Medicine at the University of California San Diego, has been named founding dean of The Herbert Wertheim School of Public Health and Human Longevity Science.

RNA Molecules in Maternal Blood May Predict Pregnancies at Risk for Preeclampsia

May 19, 2020

UC San Diego researchers have identified small molecules in the blood of asymptomatic pregnant women that may predict risk for preeclampsia, responsible for a significant proportion of maternal and neonatal deaths, low birth weight and is a primary cause of premature birth.

NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19

May 15, 2020

The NIH has launched a major clinical trial to assess the malaria drug hydroxychloroquine and antibiotic azithromycin as a treatment for COVID-19. The trial will recruit 2,000 participants at 30 sites. A Q&A with the trial’s team leader: Davey Smith, MD, of UC San Diego School of Medicine.

Introducing the UC San Diego Return to Learn Program

May 5, 2020

Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.

Introducing the UC San Diego Return to Learn Program

May 5, 2020

Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.

$55M NIH Grant Advances Clinical and Translational Research at UC San Diego

May 4, 2020

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science (NCATS), part of the National Institutes of Health.

Clinical Trial to Investigate whether Hypertension Drug Ameliorates COVID-19 Severity

April 30, 2020

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.
Category navigation with Social links